Unbeknownst to them, at least 1 percent of the US population has an identifiable genetic risk for cancer or heart disease that could be detected and clinically managed through genomic screening. Researchers say that identifying those 3 to 4 million persons and effectively mitigating that risk are worthy goals, but more work is needed before genomic screening becomes routine in health care.